StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research note published on Monday. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens upped their price objective on shares of Veradigm from $7.00 to $13.00 and gave the company an “equal weight” rating in a research report on Friday, January 31st.
Read Our Latest Stock Report on MDRX
Veradigm Trading Down 8.9 %
About Veradigm
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- How to Use High Beta Stocks to Maximize Your Investing Profits
- What GTC 2025 Signals for NVIDIA Stock’s Next Big Move
- Best of the list of Dividend Aristocrats: Build wealth with the aristocrat index
- Alphabet’s Officially In A Bear Market—Time To Buy?
- Are Penny Stocks a Good Fit for Your Portfolio?
- D-Wave and Quantum Supremacy: Implications For Investors
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
